Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape
Year: 2024
Type: article
Abstract: Lauren Coyle, Commissioning Editor of Immuno-Oncology Insights, speaks with Oliver Rosen, Chief Medical Officer of Akamis Bio, to discuss the impact of accurate patient selection on the effectiveness of I-O treatments and the limitations of current biomarkers in patient selection.
Source: Immuno Oncology Insights
Author: Oliver Rosen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7115592948
FWCI:
Cites:
Cited by:
Related to: